ADVANCED_MEDICAL_SIMULATI - Accounts


Company Registration No. 09928037 (England and Wales)
ADVANCED MEDICAL SIMULATION ONLINE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2018
PAGES FOR FILING WITH REGISTRAR
ADVANCED MEDICAL SIMULATION ONLINE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
ADVANCED MEDICAL SIMULATION ONLINE LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2018
31 December 2018
- 1 -
2018
2017
Notes
£
£
£
£
Fixed assets
Tangible assets
3
20,601
36,893
Current assets
Debtors
4
1,374
2,649
Cash at bank and in hand
4,799
3,762
6,173
6,411
Creditors: amounts falling due within one year
5
(14,029)
(16,008)
Net current liabilities
(7,856)
(9,597)
Total assets less current liabilities
12,745
27,296
Capital and reserves
Called up share capital
6
400
200
Profit and loss reserves
12,345
27,096
Total equity
12,745
27,296

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 24 September 2019 and are signed on its behalf by:
Dr N N Amso
Director
Company Registration No. 09928037
ADVANCED MEDICAL SIMULATION ONLINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2018
- 2 -
1
Accounting policies
Company information

Advanced Medical Simulation Online Limited is a private company limited by shares, company number 09928037, incorporated in England and Wales. The registered office is 62 Ely Road, Cardiff, Wales, CF5 2JG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

ADVANCED MEDICAL SIMULATION ONLINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2018
1
Accounting policies
(Continued)
- 3 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.10
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

ADVANCED MEDICAL SIMULATION ONLINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2018
- 4 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 3 (2017 - 3).

3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2018
56,679
Additions
3,902
At 31 December 2018
60,581
Depreciation
At 1 January 2018
19,786
Depreciation charged in the year
20,194
At 31 December 2018
39,980
Carrying amount
At 31 December 2018
20,601
At 31 December 2017
36,893
4
Debtors
2018
2017
Amounts falling due within one year:
£
£
Trade debtors
-
640
Corporation tax recoverable
-
1,333
Other debtors
1,374
676
1,374
2,649
5
Creditors: amounts falling due within one year
2018
2017
£
£
Trade creditors
-
240
Corporation tax
(1,333)
-
Other taxation and social security
379
444
Other creditors
14,983
15,324
14,029
16,008
ADVANCED MEDICAL SIMULATION ONLINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2018
- 5 -
6
Called up share capital
2018
2017
£
£
Ordinary share capital
Issued and fully paid
200 (2017: 100) Ordinary 'A' Shares of £1 each
200
100
200 (2017: 100) Ordinary 'B' Shares of £1 each
200
100
400
200

During the year 100 ordinary 'A' shares and 100 ordinary 'B' shares were issued.

7
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2018
2017
£
£
14,497
8,108
2018-12-312018-01-01falseCCH SoftwareCCH Accounts Production 2019.200No description of principal activity24 September 2019Dr J L ScottDr N N Amso099280372018-01-012018-12-31099280372018-12-31099280372017-12-3109928037core:OtherPropertyPlantEquipment2018-12-3109928037core:OtherPropertyPlantEquipment2017-12-3109928037core:CurrentFinancialInstruments2018-12-3109928037core:CurrentFinancialInstruments2017-12-3109928037core:ShareCapital2018-12-3109928037core:ShareCapital2017-12-3109928037core:RetainedEarningsAccumulatedLosses2018-12-3109928037core:RetainedEarningsAccumulatedLosses2017-12-3109928037core:ShareCapitalOrdinaryShares2018-12-3109928037core:ShareCapitalOrdinaryShares2017-12-3109928037bus:Director22018-01-012018-12-3109928037core:PlantMachinery2018-01-012018-12-3109928037core:OtherPropertyPlantEquipment2017-12-3109928037core:OtherPropertyPlantEquipment2018-01-012018-12-3109928037bus:PrivateLimitedCompanyLtd2018-01-012018-12-3109928037bus:FRS1022018-01-012018-12-3109928037bus:AuditExemptWithAccountantsReport2018-01-012018-12-3109928037bus:SmallCompaniesRegimeForAccounts2018-01-012018-12-3109928037bus:Director12018-01-012018-12-3109928037bus:FullAccounts2018-01-012018-12-31xbrli:purexbrli:sharesiso4217:GBP